Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings
Publication date: Available online 15 October 2026 Source: Endocrine Practice Author(s): Nathaly Cuervo-Pardo, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, Diana Barb, Anu Sharma, Jens Rosenberg, Fernando Bril, Margery A. Connelly, Joseph R. Grajo, Juan Pablo Perdomo, Juan Manuel Muñoz Peña, Enrique Valdez Saenz, Romina Lomonaco, Thao A. Nguyen, Pierre Bedossa, Kenneth Cusi
Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings. // Endocrine Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1530891X26012887?dgcid=rss_sd_all
Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings. Endocrine Practice. https://www.sciencedirect.com/science/article/pii/S1530891X26012887?dgcid=rss_sd_all
“Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings.” Endocrine Practice.
@article{article89151,
title = {Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings},
journal = {Endocrine Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1530891X26012887?dgcid=rss_sd_all}
}